Pure Global
NCT06370845

Abundance of a Natural Odour in Human Cerebrospinal Fluid After Olfactory Exposure

Abundance of a Natural Odour in Human Cerebrospinal Fluid After Olfactory Exposure - the OLFO-Brain Study
University Hospital, Basel, Switzerland·Phase 1·ClinicalTrials.gov·combination productNot yet recruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Overweight and Obesity
Drug/Device/Intervention
Inhalation - Natural Odour
Study type
Interventional
Intervention type
combination product
Sponsor & location
Primary sponsor
University Hospital, Basel, Switzerland
Location
Basel, Switzerland
Timeline & enrollment
Phase
Phase 1
Start date
May 01, 2024
End date
Oct 30, 2024
Enrollment
32 participants
Primary outcome

Detection of a natural odour in human CSF

Summary

The goal of this clinical trial is to investigate the abundance of a natural odour in human
 cerebrospinal fluid in obese and lean participants after inhalation thereof. Participants
 will undergo blood sample collection and inhalation of either a natural odour or placebo
 through an inhaler in addition to a liquor puncture prescribed in standard of care context.

ICD-10 classifications
ObesityOther obesityObesity due to excess caloriesObesity, unspecifiedObesity and other hyperalimentation
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06370845
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06370845 through Pure Global AI's free database. This Phase 1 trial is sponsored by University Hospital, Basel, Switzerland and is currently Not yet recruiting. The study focuses on Overweight and Obesity. Target enrollment is 32 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.